- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Opioids Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Opioids Drug market size is estimated to be worth US$ 10340 million in 2021 and is forecast to a readjusted size of USD 9156.6 million by 2028 with a CAGR of -1.7% during review period. Pain Relief accounting for % of the Opioids Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oxycodone segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Opioids Drug include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, and Collegium, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Opioids Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oxycodone
Hydromorphone
Codeine
Fentanyl
Market segment by Application can be divided into
Pain Relief
Anesthesia
Others
The key market players for global Opioids Drug market are listed below:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales, revenue and global market share of Opioids Drug from 2019 to 2022.
Chapter 3, the Opioids Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Opioids Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioids Drug.
Chapter 13, 14, and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Opioids Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Global Opioids Drug Market Size & Forecast
1.4.1 Global Opioids Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Opioids Drug Sales in Volume (2017-2028)
1.4.3 Global Opioids Drug Price (2017-2028)
1.5 Global Opioids Drug Production Capacity Analysis
1.5.1 Global Opioids Drug Total Production Capacity (2017-2028)
1.5.2 Global Opioids Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioids Drug Market Drivers
1.6.2 Opioids Drug Market Restraints
1.6.3 Opioids Drug Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Opioids Drug Product and Services
2.1.4 Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business
2.2.3 Purdue Pharma Opioids Drug Product and Services
2.2.4 Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Opioids Drug Product and Services
2.3.4 Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amneal Pharma
2.4.1 Amneal Pharma Details
2.4.2 Amneal Pharma Major Business
2.4.3 Amneal Pharma Opioids Drug Product and Services
2.4.4 Amneal Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Collegium
2.5.1 Collegium Details
2.5.2 Collegium Major Business
2.5.3 Collegium Opioids Drug Product and Services
2.5.4 Collegium Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 J&J
2.6.1 J&J Details
2.6.2 J&J Major Business
2.6.3 J&J Opioids Drug Product and Services
2.6.4 J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Endo
2.7.1 Endo Details
2.7.2 Endo Major Business
2.7.3 Endo Opioids Drug Product and Services
2.7.4 Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Opioids Drug Product and Services
2.8.4 Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 INSYS
2.9.1 INSYS Details
2.9.2 INSYS Major Business
2.9.3 INSYS Opioids Drug Product and Services
2.9.4 INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Opioids Drug Product and Services
2.10.4 Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Opioids Drug Product and Services
2.11.4 Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Opioids Drug Product and Services
2.12.4 Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Opioids Drug Breakdown Data by Manufacturer
3.1 Global Opioids Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Opioids Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Opioids Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Opioids Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Opioids Drug Manufacturer Market Share in 2021
3.5 Global Opioids Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Opioids Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Opioids Drug Market Size by Region
4.1.1 Global Opioids Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Opioids Drug Revenue by Region (2017-2028)
4.2 North America Opioids Drug Revenue (2017-2028)
4.3 Europe Opioids Drug Revenue (2017-2028)
4.4 Asia-Pacific Opioids Drug Revenue (2017-2028)
4.5 South America Opioids Drug Revenue (2017-2028)
4.6 Middle East and Africa Opioids Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Opioids Drug Sales in Volume by Type (2017-2028)
5.2 Global Opioids Drug Revenue by Type (2017-2028)
5.3 Global Opioids Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Opioids Drug Sales in Volume by Application (2017-2028)
6.2 Global Opioids Drug Revenue by Application (2017-2028)
6.3 Global Opioids Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Opioids Drug Sales by Type (2017-2028)
7.2 North America Opioids Drug Sales by Application (2017-2028)
7.3 North America Opioids Drug Market Size by Country
7.3.1 North America Opioids Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Opioids Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Opioids Drug Sales by Type (2017-2028)
8.2 Europe Opioids Drug Sales by Application (2017-2028)
8.3 Europe Opioids Drug Market Size by Country
8.3.1 Europe Opioids Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Opioids Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Opioids Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Opioids Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Opioids Drug Market Size by Region
9.3.1 Asia-Pacific Opioids Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Opioids Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Opioids Drug Sales by Type (2017-2028)
10.2 South America Opioids Drug Sales by Application (2017-2028)
10.3 South America Opioids Drug Market Size by Country
10.3.1 South America Opioids Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Opioids Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Opioids Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Opioids Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Opioids Drug Market Size by Country
11.3.1 Middle East & Africa Opioids Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Opioids Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Opioids Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Opioids Drug
12.3 Opioids Drug Production Process
12.4 Opioids Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Opioids Drug Typical Distributors
13.3 Opioids Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Opioids Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Opioids Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Opioids Drug Product and Services
Table 6. Teva Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Purdue Pharma Major Business
Table 9. Purdue Pharma Opioids Drug Product and Services
Table 10. Purdue Pharma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Opioids Drug Product and Services
Table 14. Mallinckrodt Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Amneal Pharma Major Business
Table 17. Amneal Pharma Opioids Drug Product and Services
Table 18. Amneal Pharma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Collegium Basic Information, Manufacturing Base and Competitors
Table 20. Collegium Major Business
Table 21. Collegium Opioids Drug Product and Services
Table 22. Collegium Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. J&J Basic Information, Manufacturing Base and Competitors
Table 24. J&J Major Business
Table 25. J&J Opioids Drug Product and Services
Table 26. J&J Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Endo Basic Information, Manufacturing Base and Competitors
Table 28. Endo Major Business
Table 29. Endo Opioids Drug Product and Services
Table 30. Endo Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Opioids Drug Product and Services
Table 34. Pfizer Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. INSYS Basic Information, Manufacturing Base and Competitors
Table 36. INSYS Major Business
Table 37. INSYS Opioids Drug Product and Services
Table 38. INSYS Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Opioids Drug Product and Services
Table 42. Mylan Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Hikma Basic Information, Manufacturing Base and Competitors
Table 44. Hikma Major Business
Table 45. Hikma Opioids Drug Product and Services
Table 46. Hikma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Egalet Basic Information, Manufacturing Base and Competitors
Table 48. Egalet Major Business
Table 49. Egalet Opioids Drug Product and Services
Table 50. Egalet Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Opioids Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Units)
Table 52. Global Opioids Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Opioids Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Opioids Drug Production Capacity by Company, (M Units): 2020 VS 2021
Table 55. Head Office and Opioids Drug Production Site of Key Manufacturer
Table 56. Opioids Drug New Entrant and Capacity Expansion Plans
Table 57. Opioids Drug Mergers & Acquisitions in the Past Five Years
Table 58. Global Opioids Drug Sales by Region (2017-2022) & (M Units)
Table 59. Global Opioids Drug Sales by Region (2023-2028) & (M Units)
Table 60. Global Opioids Drug Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Opioids Drug Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 63. Global Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 64. Global Opioids Drug Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Opioids Drug Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Opioids Drug Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Opioids Drug Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 69. Global Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 70. Global Opioids Drug Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Opioids Drug Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Opioids Drug Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Opioids Drug Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 75. North America Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 76. North America Opioids Drug Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Opioids Drug Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 79. North America Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 80. North America Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 81. North America Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 82. Europe Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 83. Europe Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 84. Europe Opioids Drug Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Opioids Drug Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 87. Europe Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 88. Europe Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 89. Europe Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 90. Asia-Pacific Opioids Drug Sales by Region (2017-2022) & (M Units)
Table 91. Asia-Pacific Opioids Drug Sales by Region (2023-2028) & (M Units)
Table 92. Asia-Pacific Opioids Drug Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Opioids Drug Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 95. Asia-Pacific Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 96. Asia-Pacific Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 97. Asia-Pacific Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 98. South America Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 99. South America Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 100. South America Opioids Drug Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Opioids Drug Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 103. South America Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 104. South America Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 105. South America Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 106. Middle East & Africa Opioids Drug Sales by Region (2017-2022) & (M Units)
Table 107. Middle East & Africa Opioids Drug Sales by Region (2023-2028) & (M Units)
Table 108. Middle East & Africa Opioids Drug Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Opioids Drug Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 111. Middle East & Africa Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 112. Middle East & Africa Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 113. Middle East & Africa Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 114. Opioids Drug Raw Material
Table 115. Key Manufacturers of Opioids Drug Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Opioids Drug Typical Distributors
Table 119. Opioids Drug Typical Customers
List of Figures
Figure 1. Opioids Drug Picture
Figure 2. Global Opioids Drug Revenue Market Share by Type in 2021
Figure 3. Oxycodone
Figure 4. Hydromorphone
Figure 5. Codeine
Figure 6. Fentanyl
Figure 7. Global Opioids Drug Revenue Market Share by Application in 2021
Figure 8. Pain Relief
Figure 9. Anesthesia
Figure 10. Others
Figure 11. Global Opioids Drug Revenue, (USD Million) & (M Units): 2017 & 2021 & 2028
Figure 12. Global Opioids Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Opioids Drug Sales (2017-2028) & (M Units)
Figure 14. Global Opioids Drug Price (2017-2028) & (USD/Unit)
Figure 15. Global Opioids Drug Production Capacity (2017-2028) & (M Units)
Figure 16. Global Opioids Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Opioids Drug Market Drivers
Figure 18. Opioids Drug Market Restraints
Figure 19. Opioids Drug Market Trends
Figure 20. Global Opioids Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Opioids Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Opioids Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Opioids Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Opioids Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Opioids Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Opioids Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Opioids Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Opioids Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Opioids Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Opioids Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Opioids Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Opioids Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Opioids Drug Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Opioids Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Opioids Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Opioids Drug Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Opioids Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Opioids Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Opioids Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Opioids Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Opioids Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Opioids Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Opioids Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Opioids Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Opioids Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Opioids Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Opioids Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Opioids Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Opioids Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Opioids Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Opioids Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Opioids Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Opioids Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Opioids Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Opioids Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Opioids Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Opioids Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Opioids Drug in 2021
Figure 79. Manufacturing Process Analysis of Opioids Drug
Figure 80. Opioids Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
